The UK CPAP market is projected to reach USD 222.8 million in the year 2025 and is expected to total USD 305.2 million by the end of 2035, growing at a compound annual growth rate (CAGR) of 3.2% over the forecast years from 2025 to 2035.
| Attributes | Values |
|---|---|
| Estimated Industry Size 2025 | USD 222.8 million |
| Projected Value 2035 | USD 305.2 million |
| Value-based CAGR from 2025 to 2035 | 3.2% |
The aging population is driving the demographic as the volume of patients diagnosed with OSA continually increases. Early diagnosis and treatment of sleep-related disorders, further adding to market expansion, are some of the healthcare systems. Awareness and reimbursement policies related to sleep apnea have helped to significantly boost the adoption rate through government initiatives.
Advancements in technology is also another important factor for CPAP in UK. The company is constantly inventing to make the patient more comfortable with less noise of the device, improved mask fit, and the use of AI-driven monitoring systems that monitor real-time data. There also is a trend for portable, travel-friendly CPAP devices to meet the rising needs of moving yet not at the cost of efficiency of treatment.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The table below offers a detailed comparative assessment of the changes in the compound annual growth rate (CAGR) over six months for the base year (2023) and the current year (2024) specifically for the UK continuous positive airway pressure (CPAP) market.
This semiannual analysis highlights all the critical shifts of market dynamics as well as details the revenue realization pattern, thus more precisely providing to the stakeholders insight into the trajectory of growth within a year. In other words, H1 contains January to June, and the other half H2 contains July to December.
-market-actual-vs-estimated-cagr.png "Uk Continuous Positive Airway Pressure (cpap) Market Actual Vs Estimated Cagr")
H1 signifies period from January to June, H2 Signifies period from July to December
UK market is expected to grow in the CPAP sector at a CAGR of 3.7% in H1 of 2023, and by second half, it should be greater than 3.5%. This is expected to decline a bit at 3.2% in H1 of 2024. The same, however, should be up by H2 to 3.9%. This would represent a decrease of 21 basis points from the first half of 2023 to the first half of 2024 and was higher by 15 basis points in the second half of 2024 compared to the second half of 2023.
These figures represent a dynamic and fast-changing UK continuous positive airway pressure (CPAP) market, largely influenced by regulations, consumer trends, and improvements in continuous positive airway pressure (CPAP). This semestral breakup is crucial to businesses that chart their strategies, taking into consideration the growth trends and navigating market complexities.
| Date | Development/M&A Activity & Details |
|---|---|
| 2025 | Product Innovation: Hebei Topson Medical Technology Co., Ltd. company is prioritizing innovation to introduce novel products in the market. They are trying to keep their products within the costeffective bracket to increase their adoption. |
| 2024 | Research and Development: Medtronic prioritizes research and development to create cutting-edge medical technologies. The company invests heavily in understanding patient needs and leveraging data insights to improve treatment outcomes. Strategic effort is directed toward areas where Medtronic can make significant and unique contributions to healthcare. |
| 2024 | Expansion: Nanjing Superstar Medical Equipment Co., Ltd. has expanded its geographical reach significantly. This global presence allows them to tap into diverse markets and increase their customer base |
Main factors affecting the UK market are growth in the rate of respiratory diseases, especially obstructive sleep apnea. Concomitant with an increased prevalence of obesity and older-age associated health problems, growing awareness of sleep disorders has led to more frequent diagnoses that assure greater growth.
The initiatives that are supported by the government, along with positive reimbursement policies, make CPAP therapy accessible to all patients, leading to widespread use and better outcomes for patients. Another factor has been the proactive UK approach toward tackling sleep apnea through public health campaigns and screening programs.
% share of Individual categories by Product Type and End User in 2025
-market-total-vs-top-selling-product.png "Uk Continuous Positive Airway Pressure (cpap) Market Total Vs Top Selling Product")
The standard care to treat sleep apnea and other respiratory disorders now encompasses PAP treatment, such as CPAP, BiPAP, and APAP, primarily throughout the UK. With increasing incidences of sleep disorders, escalating rates of obesity, and raising awareness of undiagnosed sleep apnea among the general population, these numbers continue to climb.
Insurance plans are bettering their cover and reimbursements of the treatments provided through PAP to attract both the patient and health service provider more than ever before.
Hopping onto the wide scale and widespread usage of PAP devices lies the hospitals because it is always in the fore in diagnosing and managing respiratory conditions. Most of the patients first experience CPAP or BiPAP therapy in a sleep study at the hospital-based sleep center.
In addition, PAP devices play an important role in critical care settings, including intensive care units and emergency departments, where non-invasive ventilation is used to treat conditions such as COPD, pneumonia, and respiratory failure following surgery. In addition to higher amounts of demand for early diagnosis, hospitalization rates for respiratory diseases are also growing, thereby increasing the demand for PAP devices in the UK.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The UK CPAP (Continuous Positive Airway Pressure) market is relatively moderate in concentration; however, with a few players dominating the business, and small companies have still been able to introduce something new. Key global brands Philips Respironics, ResMed, and Fisher & Paykel Healthcare have considerable shares in the market, with high brand value, product variety, and better distribution channels.
These companies have been leaders in the CPAP market as they always maintain dedication towards technology innovation, product quality, and customer support. The leading companies constantly innovate through new features, such as quieter machines, automatic pressure adjustments, smart connectivity for remote monitoring, etc. that aim to improve comfort, usability, and effectiveness.
Affordability and insurance coverage for sleep apnea solutions have received increasing demands by the market over time. The company that can price competitively yet be compatible with reimbursement policies stands to gain the most in the market.
2025 Market share of UK Continuous Positive Airway Pressure (CPAP) suppliers
-market-revanue-share-by-compony-2025.png "Uk Continuous Positive Airway Pressure (cpap) Market Revanue Share By Compony 2025")
Note: above chart is indicative in nature
In terms of product, the industry is divided into PAP Devices (CPAP, BIPAP, and Auto CPAP), Humidifier, Masks (Full Face Masks, Nasal Masks, and Nasal Pillow Masks) and Accessories.
In terms of patient type, the industry is segregated into infants, premature, adults.
In terms of indication, the industry is segregated into chronic respiratory failure, respiratory distress syndrome (RDS), sleep apnea disorders, hypoxemia and hypoxia, among other indications.
In terms of end user, the industry is divided into hospitals, home care settings, clinics, intensive care units and sleep disorder centers.
By 2025, the UK continuous positive airway pressure (CPAP) market is expected to grow at a CAGR of 3.2%.
By 2035, the sales value of the UK continuous positive airway pressure (CPAP) industry is expected to reach UK is 305.2 million.
The key drivers fueling the growth of the UK continuous positive airway pressure (CPAP) market include the increasing incidence of chronic respiratory disorders and the growing obesity rates.
Prominent players in the UK continuous positive airway pressure (CPAP) manufacturing include ResMed, Fisher & Paykel Healthcare, Draegerwerk AG & Co. KGaA, Medtronics, ReactHealth (3B Medical, Inc.), DeVilbiss Healthcare, Armstrong Medical, BMC Medical Co. Ltd, Hamilton Medical AG, Hebei Topson Medical Technology Co., Ltd., Nanjing Superstar Medical Equipment, SS TECHNOMED, Inspiration Healthcare(Viomedex Limited), Pigeon Medical and Others. These companies are noted for their innovation, extensive product portfolios, and strategic market positioning.
Explore Therapeutic Device Insights
View Reports
UK Continuous Positive Airway Pressure (CPAP) Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
